The infusion pump market is expected to grow at a CAGR of 5.43% from US$11.101 billion in 2025 to US$14.458 billion in 2030
Infusion pumps play a crucial role in the medical field, efficiently delivering controlled amounts of fluids, such as medications and nutrients, into patients' bodies. Widely utilized in diverse settings like hospitals, nursing homes, and even at home, these devices offer numerous advantages over manual administration. Operated by trained users, infusion pumps work with a user-friendly software interface that allows precise programming of fluid delivery rates and durations. This capability enables the delivery of fluids in small volumes and at automated intervals, enhancing accuracy and reliability in medical treatments. The range of substances administered through infusion pumps includes vital medications like insulin, hormones, antibiotics, chemotherapy drugs, and pain relievers.
Various types of infusion pumps cater to specific needs, including large-volume pumps, patient-controlled analgesia (PCA) pumps, elastomeric pumps, syringe pumps, enteral pumps, and insulin pumps. Some pumps are stationary and primarily bedside-based, while others, known as ambulatory infusion pumps, are designed to be portable or wearable for greater flexibility.
Infusion pumps may be powered either electrically or mechanically, and their operational mechanisms vary across different types. For instance, in syringe pumps, a movable piston controls fluid delivery within a syringe reservoir. Elastomeric pumps utilize a stretchable balloon reservoir, where pressure from the elastic balloon walls propels fluid delivery. Peristaltic pumps employ a set of rollers to pinch down on flexible tubing, pushing fluid forward. Meanwhile, multi-channel pumps allow the delivery of fluids from multiple reservoirs at distinct rates. Overall, the versatility and precision of infusion pumps make them indispensable tools in modern healthcare.
The World Health Organization (WHO) has expressed concern about the escalating toll of non-communicable diseases (NCDs), projecting that if current trends persist, chronic conditions like cardiovascular diseases, cancer, diabetes, and respiratory illnesses will constitute a staggering 86% of the 90 million annual deaths by around 2050. The prevalence of many chronic diseases is attributed to a concise list of risk behaviors, including tobacco use and exposure to secondhand smoke, inadequate nutrition marked by low fruit and vegetable intake and high sodium and saturated fat consumption, physical inactivity, and excessive alcohol use. In response to the escalating prevalence of chronic diseases, governments worldwide are witnessing a notable rise in healthcare spending. This financial commitment is driven by the need to address the complex factors contributing to NCDs.
In the United States, health spending experienced a 4.1% increase in 2023, reaching $4.8 trillion or $14,424 per capita. Although this growth rate is lower than that of 2020 (10.3%), it underscores the significant financial burden of addressing the rising prevalence of chronic diseases.
Among European Union Member States, Germany leads in current healthcare expenditure, reaching EUR 487 billion in 2022, followed by France at EUR 305 billion, Italy at EUR 169 billion, and Spain at EUR 130 billion. Germany and France's healthcare expenditures accounted for 12.8% and 12.2% of their respective gross domestic product (GDP). These figures underscore the growing financial commitment by governments to address the healthcare challenges posed by the increasing prevalence of chronic ailments and evolving lifestyles.
These trends in healthcare spending are intricately linked with the broader healthcare market, influencing the demand for medical technologies such as infusion pumps. The evolving landscape underscores the imperative of adapting healthcare systems to effectively manage the rising burden of chronic diseases.
The global landscape is currently undergoing significant transformations due to demographic shifts. In the Asia-Pacific (APAC) region, the proportion of individuals aged 60 or older was approximately 12.4% in 2016. Projections indicate a substantial increase, exceeding a quarter of the population, or 1.3 billion people, by the year 2050. This demographic transition highlights the escalating healthcare demands in the region, particularly in east and north Asia, which includes countries like Japan and the Republic of Korea, where over a third of the population is expected to be aged 60 or older by 2050.
Similarly, the European Union (EU) is witnessing a direct correlation between its aging population and the demand for infusion pumps. The population of individuals aged 65 or more in the EU-27 is poised for a significant surge, rising from 91.4 million in 2023 to 129.8 million by 2050. Within this timeframe, the segment aged 75-84 years is projected to experience a notable growth of 56.1%, while the group aged 65-74 years is anticipated to increase by 16.6%.
In the United States, the growth in the older population has seen a remarkable spike from 2010 to 2020, with a growth rate of 38.6%, soaring from 40.3 million to 55.8 million. This growth is more than twice as fast as the previous decade, highlighting a significant demographic shift.
Within the context of the infusion pump market and healthcare, a discernible global trend emerges where the older population is expanding at an accelerated rate. This underscores the rising importance of healthcare technologies, including the demand for infusion pumps, as indispensable components in addressing the evolving healthcare needs associated with the aging global population.
Infusion pumps, as intricate medical devices, pose inherent risks of malfunction or software defects, potentially leading to product recalls and causing significant financial and reputational damage to manufacturers. A recent illustration of such challenges occurred in September 2023, when Becton Dickinson (BD)/CareFusion 303 initiated a recall of Alaris Infusion Pumps due to compatibility issues with Cardinal Health Monoject Syringes. The Alaris infusion pump, designed as a modular system, is primarily intended for the precise delivery of medications or other fluids. Notably, the syringe and PCA pump modules undergo validation for use exclusively with specific syringes, highlighting the critical nature of ensuring compatibility to avoid adverse incidents and maintain the integrity of healthcare delivery systems.
By Type, the Infusion Pump Market Is Segmented into Insulin Pump, PCA Pump, Enteral Pump
The infusion pump market is segmented into insulin, PCA, and enteral pumps, each serving distinct medical needs. Patient-controlled analgesia (PCA) pumps offer patient autonomy in administering pain medication. Insulin pumps, commonly used in homes, provide a controlled delivery system for diabetes management. An enteral pump is employed to administer liquid nutrients and medications directly to a patient's digestive tract.
North America Is Anticipated to Hold a Significant Share of the Infusion Pump Market
North America is poised to command a notable share in the Infusion Pump Market. Recent data from the American Hospital Association underscores the resilience of the U.S. healthcare landscape, with a notable increase in the total count of U.S. hospitals from 6,093 in 2022 to 6,120 in 2024. The scale of medical activities is emphasized by the cumulative hospital admissions, reaching 34,113,745 in 2024, with 33,356,853 admissions recorded in 2022 (Projections based on AFA). Canada is witnessing a significant trajectory in health spending, projected to reach $344 billion in 2024, or $8,843 per Canadian (Projections based on CIHI). Anticipated growth in spending is driven by deferred care returning post-pandemic, contributing to an increase in healthcare services. Demographic factors, including population aging and growth, further fuel spending growth, fostering a conducive environment for overall healthcare facilities, including infusion pumps.
The global infusion pump market report deep-dives into the global industry landscape and provides a strategic and executive level-level insights complemented by data-driven analysis and forecasts. The report is updated regularly to help the decision-makers with actionable intelligence into the current market trends, emerging opportunities and competitive intelligence. The report also explores the demand for different types of infusion pump such as, insulin pump, PCA pump, enteral pump, and others showcases their demand across geographies. The latest technological advancements in the infusion pump market in addition to key government policies and regulations and macroeconomic factors are also analyzed to present a holistic view of the market.
The Infusion Pump Market is analysed By Type into the following:
Infusion Pump Market Segmentation By Mechanism:
Syringe pump is one of the largest market segments. The report analysed the Infusion Pump Market into different mechanism as below:
Infusion Pump Market Segmentation By Application:
The report analysed the infusion pump market across application as following:
Infusion Pump Market Segmentation By Region:
The study also analysed the Infusion Pump Market into the following regions, with country level forecasts and analysis as below:
The global Infusion Pump Market is marked by the presence of key players such as Baxter International Inc., Becton, Dickinson and Company (BD), B. Braun Melsungen AG., Johnson & Johnson, Medtronic plc., Nipro Corporation, Biomedix Medical, Eitan Medical, Smiths Medical (ICU Medical), and Terumo Corporation among others.
This report provides extensive coverage as explained in the points below:
How this report is helpful to you and reasons for purchase?
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Infusion Pump Market Size in 2025 | US$11.101 billion |
| Infusion Pump Market Size in 2030 | US$14.458 billion |
| Growth Rate | CAGR of 5.43% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Billion |
| Segmentation |
|
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in the Infusion Pump Market | |
| Customization Scope | Free report customization with purchase |